Triple
T13959325
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Delta variant |
E335749
|
entity |
| Predicate | relativeVaccineEffectiveness |
P112412
|
FINISHED |
| Object | Reduced infection protection compared to earlier variants |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Reduced infection protection compared to earlier variants | Statement: [Delta variant, relativeVaccineEffectiveness, Reduced infection protection compared to earlier variants]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: relativeVaccineEffectiveness Context triple: [Delta variant, relativeVaccineEffectiveness, Reduced infection protection compared to earlier variants]
-
A.
vaccineUsed
Indicates that a particular vaccine has been administered or applied in a given medical or experimental context.
-
B.
impactOnNeutralizingAntibodies
Indicates the effect that something has on the presence, level, or effectiveness of neutralizing antibodies.
-
C.
encodesInVaccines
Indicates that one entity (such as genetic material or information) is incorporated into or represented within the formulation of a vaccine.
-
D.
covid19VaccineType
Indicates the specific type or category of COVID-19 vaccine associated with an entity.
-
E.
efficacyAgainstSymptomaticCOVID19
Indicates the degree to which an intervention reduces the occurrence of symptomatic COVID-19 in a population compared to a control condition.
- F. None of above. chosen
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d81c61f3508190aaf2ca0dc0002c59 |
completed | April 9, 2026, 9:38 p.m. |
| NER | Named-entity recognition | batch_69de2e7b2f908190aa32f22298964746 |
completed | April 14, 2026, 12:09 p.m. |
| PD | Predicate disambiguation | batch_69de05a3ccf88190b45c742db483fa08 |
completed | April 14, 2026, 9:15 a.m. |
| PDg | Predicate description generation | batch_69de239524688190a0f2408c239cfcaa |
completed | April 14, 2026, 11:23 a.m. |
Created at: April 9, 2026, 10:17 p.m.